Swiss biopharmaceutical company AC Immune announced that its partner radiopharmaceutical firm Life Molecular Imaging (LMI, formerly Piramal Imaging) presented new clinical study results for F-18 PI-2620, a novel tau PET-tracer, at the recent Clinical Trials on Alzheimer's Disease Conference in Barcelona, Spain.
Intracellular tau deposition is a key pathologic feature of Alzheimer's disease and other neurodegenerative disorders. The results of the test-retest study for F-18 PI-2620 in Alzheimer's disease and nondemented controls demonstrated favorable kinetics, high target specificity with low off-target binding, and high signal in regions of expected tau pathology.
The low test-retest variability will allow for precise quantification of F-18 PI-2620 uptake in target brain areas to detect subtle changes of tau deposition over time and during therapeutic interventions in longitudinal studies, the firms said.










![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)








